| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/18/2011 | US20110201587 Hsp90 inhibitors and methods of use |
| 08/18/2011 | US20110201579 Method of Improving the Overall Health of a Patient by Application of Pregnenolone |
| 08/18/2011 | US20110201574 Fatty acid amide hydrolase inhibitors |
| 08/18/2011 | US20110201569 Methods For Treating Myocardial Disorders |
| 08/18/2011 | US20110201564 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof |
| 08/18/2011 | US20110201542 Myeloid Protein Activation of Anti-Inflammatory and Anti-Hypoxic Pathway |
| 08/18/2011 | US20110200697 Compositions for Prophylaxis or Treatment of Cerebrovascular Diseases, for Improving Memory Impairment, or for Protecting Neuronal Cells, Containing Ethanol Extract from Aralia Elata, Chaenomelis Fructus and Glycyrrhizae Radix |
| 08/18/2011 | US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer |
| 08/18/2011 | US20110200645 DHA Free Fatty Acid Emulsions |
| 08/18/2011 | US20110200625 Pharmaceutical composition |
| 08/18/2011 | US20110200613 Use of B Cell Expansion Agents in Generating Antibodies |
| 08/18/2011 | US20110200612 Treatment of eye diseases and excessive neovascularization using combined therapy |
| 08/18/2011 | US20110200611 Plasma kallikrein binding proteins |
| 08/18/2011 | US20110200587 Aminothiazolones as estrogen related receptor-alpha modulators |
| 08/18/2011 | US20110200586 Aminothiazolones as estrogen related receptor-alpha modulators |
| 08/18/2011 | US20110200579 Novel gene disruptions, compositions and methods relating thereto |
| 08/18/2011 | US20110200568 Induced pluripotent stem cells |
| 08/18/2011 | US20110200555 Conjugates of hydroxyalkyl starch and a protein |
| 08/18/2011 | US20110200541 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 08/18/2011 | US20110200539 Sprayable composition comprising extract of red vine leaves |
| 08/18/2011 | US20110200533 Compounds for the diagnosis of diseases associated with vcam expression |
| 08/18/2011 | CA2789806A1 5-ht receptor modulators |
| 08/18/2011 | CA2789485A1 Compositions and methods for the treatment of cardiac and vascular disease |
| 08/17/2011 | EP2357200A1 Human antibodies that bind human TNFalpha |
| 08/17/2011 | EP2357175A1 isoquinoline derivatives AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN |
| 08/17/2011 | EP2357171A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 08/17/2011 | EP2357165A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders |
| 08/17/2011 | EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2357004A1 NRG-2 nucleic acid molecules, polypeptides and diagnostic and therapeutical methods |
| 08/17/2011 | EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation |
| 08/17/2011 | EP2356998A1 A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (PRL)-growth hormone (GH) - placental lactogen (PL)-family protein |
| 08/17/2011 | EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof |
| 08/17/2011 | EP2356123A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes |
| 08/17/2011 | EP2356097A2 Highly pure ranolazine or a pharmaceutically acceptable salt thereof |
| 08/17/2011 | EP2355836A2 Compositions and methods for promoting vascular barrier function and treating pulmonary fibrosis |
| 08/17/2011 | EP2355814A2 Pyrones for the treatment of metabolic disorders |
| 08/17/2011 | EP2355812A2 A method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosclerosis |
| 08/17/2011 | EP2355811A2 Therapeutic compositions |
| 08/17/2011 | EP2355810A2 Methods for preventing or reducing carcinogenesis or oxidative stress |
| 08/17/2011 | EP2355807A1 Inhibitors of dimethylarginine dimethylaminohydrolase |
| 08/17/2011 | EP2355801A1 Statin nanoparticles |
| 08/17/2011 | EP2355657A1 Compositions and methods of treating endothelial disorders |
| 08/17/2011 | EP2268644B1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 08/17/2011 | EP2081927B1 Piperidine derivatives as renin inhibitors |
| 08/17/2011 | EP1848425B1 Therapeutic combinations of manidi pine and simvastatin |
| 08/17/2011 | EP1687295B1 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 08/17/2011 | EP1507558B1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2011 | EP1474134B1 Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ramipril for preventing or blocking heart failure |
| 08/17/2011 | EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 08/17/2011 | EP1444233B1 A2b adenosine receptor antagonists |
| 08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 08/17/2011 | EP1246808B1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 08/17/2011 | CN201928937U 桑叶除臭脱涩设备 Mulberry deodorant Deastringency equipment |
| 08/17/2011 | CN1898261B Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 08/17/2011 | CN1829511B Use of telmisartan and amlodipine or Nifedipine in preparing medicine for increasing insulin sensitivity |
| 08/17/2011 | CN1715926B Use of neuregulin mutant |
| 08/17/2011 | CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses |
| 08/17/2011 | CN102159582A Oxazolopyrimidines as edg-1 receptor agonists |
| 08/17/2011 | CN102159573A Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 08/17/2011 | CN102159572A Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 08/17/2011 | CN102159566A Pyridone and pyridazone analogues as gpr119 modulators |
| 08/17/2011 | CN102159547A Heterocyclic carboxamide compounds |
| 08/17/2011 | CN102159531A Cyclohexenyl modulators of chemokine receptor activity |
| 08/17/2011 | CN102159253A Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 08/17/2011 | CN102159236A Therapeutic dosing of neuregulin or subsequence thereof for treatment or prophylaxis of heart failure |
| 08/17/2011 | CN102159222A Bioactive agent,pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent |
| 08/17/2011 | CN102159200A Novel sulphur containing lipids for use as food supplement or as medicament |
| 08/17/2011 | CN102153606A Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
| 08/17/2011 | CN102153562A Spiro-oxindole compounds and their uses as therapeutic agents |
| 08/17/2011 | CN102153549A Gamma carboline compound as well as preparation method and application thereof |
| 08/17/2011 | CN102153543A Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 08/17/2011 | CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 08/17/2011 | CN102153539A 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 08/17/2011 | CN102153538A Benzocyclodirivative |
| 08/17/2011 | CN102153505A Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 08/17/2011 | CN102153498A Resveratrol analogue and preparation method and application thereof |
| 08/17/2011 | CN102153471A Idebenone succinate monoester and preparation method thereof |
| 08/17/2011 | CN102151547A Method for controlling adsorption, storage and release of guest molecules by using mesoporous material |
| 08/17/2011 | CN102151327A Traditional Chinese medicinal patch for treating coronary disease and preparation method thereof |
| 08/17/2011 | CN102151326A Combined Chinese medicine for curing hypertension and hyperlipaemia |
| 08/17/2011 | CN102151294A Heat-nourishing sedum kamtschaticum and cordyceps militaris wine |
| 08/17/2011 | CN102151291A Use of antrodia camphorata for treating diseases |
| 08/17/2011 | CN102151282A Application of iridoid glycoside and derivatives thereof as plasmin inhibitor and medicine composites of plasmin inhibitor |
| 08/17/2011 | CN102151281A Flavonoid compound for preventing and treating diabetes and medicament application thereof |
| 08/17/2011 | CN102151274A Method for stable light focusing of fasudil hydrochloride and composition obtained using same |
| 08/17/2011 | CN102151271A Use of tetrahydrofolates for modulating the homocysteine level |
| 08/17/2011 | CN102151262A Compounds for the treatment of metabolic disorders |
| 08/17/2011 | CN102151261A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 08/17/2011 | CN102151253A Nifedipine osmotic pump type controlled release tablet |
| 08/17/2011 | CN102151244A Sinomenine medicine resin slow-release suspension and preparation method thereof |
| 08/17/2011 | CN102150820A Method for preparing capsorubin and lycopene soft capsules |
| 08/17/2011 | CN101953868B Detection method for total saponins of tribulus |
| 08/17/2011 | CN101869690B Method for preparing traditional Chinese medicine for treating coronary artery disease with deficiency of both qi and yin |
| 08/17/2011 | CN101850062B Method for preparing Chinese medicament for treating heart-blood deficiency nodal tachycardia |
| 08/17/2011 | CN101850055B Chinese medicament for treating coronary heart diseases |
| 08/17/2011 | CN101843793B Chinese medicament for treating tachycardia |
| 08/17/2011 | CN101837051B New rhodobryum roseum tablet medicament composition |
| 08/17/2011 | CN101804167B Chinese drug for calming endopathic wind and reducing blood pressure and preparation method thereof |
| 08/17/2011 | CN101780089B Irbesartan hydrochlorothiazide capsule and preparation method thereof |